TMDX FY 2020 Earnings — TransMedics Group, Inc. Revenue & Financial Results | Market Cap Arena

TMDXTransMedics Group, Inc.

$5B

FY 2020 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$26M+8.6% YoY

Gross Profit

$17M64.9% margin

Operating Income

-$26M-102.9% margin

Net Income

-$29M-112.1% margin

EPS (Diluted)

$-1.16

Cash Flow

Operating Cash Flow

-$30M

Free Cash Flow

-$31M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$152M

Total Liabilities

$48M

Stockholders' Equity

$104M

Cash & Equivalents

$25M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$26M	$24M	+8.6%
Gross Profit	$17M	$14M	+20.0%
Operating Income	-$26M	-$30M	+10.9%
Net Income	-$29M	-$34M	+14.3%